Industry Roundup: J&J Trims Splenda, Hearthside Boosts Capacity
This article was originally published in The Tan Sheet
Executive Summary
Splenda in J&J’s past; Hearthside boosts bar capacity; speech supplement refunds; and more news in brief.
You may also be interested in...
Industry News: Twinlab Into Resveratrol, Hi-Tech Buys LG Brands
Consent decree for Iowa Select; Hi-Tech extends into sports nutrition with LG brands; NBTY adds another Coca-Cola exec to its top management; and more news in brief.
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.